Position in BIOA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,331,354
+$381,752 QoQ
Shares Held
190,472
-14.6% QoQ
Ownership
0.428%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $558,161,566 across 33 Drug Manufacturers - Specialty & Generic names. BIOA ranks #17 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
9,349,817 | $126,316,026 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
508,977 | $67,052,628 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
611,747 | $46,401,008 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
75,977 | $45,052,841 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
2,664,306 | $36,900,638 | |
| 6 | ALKS |
Alkermes plc.
|
999,322 | $35,336,024 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,382,412 | $33,081,118 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
748,812 | $24,763,212 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,331,354 | 190,472 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,949,602 | 222,948 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,024,272 | 174,196 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $936,638 | 226,789 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $200,787 | 53,401 | Shares | Other | 2025-05-15 | |
| 2024-09-30 | $4,159,999 | 200,000 | Shares | Other | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||